• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Health Economic Evaluation of Primary Human Papillomavirus Screening in Urban Populations in China

Health Economic Evaluation of Primary Human Papillomavirus Screening in Urban Populations in China

来源 :The 6th Biennial Conference of Asia Oceania Research Organis | 被引量 : 0次 | 上传用户：jjjjjj8610
【摘 要】
：
Background:Most women in urban populations in China do not have access to cervical screening and the role of HPV in screening low resource urban women has not been clarified.Objectives: To quantify ef
【作 者】
：
Ju-Fang Shi Rui-Fang Wu You-Lin Qiao Karen Canfell Xiao-Hong Gao Jie-Bin Lew Xiang-Ming Xu Li Ma Robert Walker Fang-Hui Zhao Jun-Feng Chen Megan A.Smith 
【机 构】
：
Department of Cancer Epidemiology,Cancer Institute&Hospital,Chinese Academy of Medical Sciences,17 S
【出 处】
：
The 6th Biennial Conference of Asia Oceania Research Organis
【发表日期】
：
2014年2期
【关键词】
：
budgetary control China economics human papillomavirus mass screening mathematic 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　Background:Most women in urban populations in China do not have access to cervical screening and the role of HPV in screening low resource urban women has not been clarified.Objectives: To quantify effectiveness and cost-effectiveness of HPV-based cervical screening in urban women in China, taking Shenzhen City, Guangdong Province as an example.
其他文献
Tobacco Use as a Risk Factor for Cervical Cancer
The role of cigarette smoking as acause of cervical cancer wasslow to be appreciated and provides an important illustration of the role of knowledge about biological mechanisms in causal inferences fr
会议
Future HPV Vaccines and Considerations for Implementation in Developing Countries
Human papillomavirus (HPV), the most common sexually transmitted virus, and its associated diseases continue to cause significant morbidity and mortality in over 600 million infected individuals.Major
会议
Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies again
A pseudovirion-based neutralisation assay (PBNA) has been considered the gold standard for measuring specific antibody responses against human papillomavirus (HPV).
会议
HPV VACCINES: Population impact of HPV vaccination: evidence from a National program
Objective:To describe the most up-to-date data on the population impact of a school-based national programme of the quadrivalent (6, 11, 16, 18) vaccine (GARDASILTM) in Australia.Methods and Conclusio
会议
Comparison of HPV genotypes and viral load between different sites of the entire genital tract the s
Objectives: To compare the consistency of HPV genotype and viral loads among different sites within the female genital tract, and to correlate these with clinical outcomes.
会议
THE FIRST VACCINE AND CERVICAL CANCER SCREEN PROJECT (VACCS1): COMBINING THE HPV-VACCINE AND SELF-SC
Background Cervical cancer is preventable but still highly prevalent in South Africa.New strategies to implement effective primary and secondary prevention technologiesinto the developing world are ur
会议
Characterization of Clonality and the effects of host genetic background on HPV DNA induced human ke
HPV immortalized human keratinocytes vary in cell morphology, growth properties,resistance to inducers of terminal differentiation, and karyotype.
会议
Recent Progress of HPV therapeutic vaccine in cervical neoplasia
Persistent human papillomavirus(HPV) infections, in particular HPV genotypes 16 and 18, are associated with the development of cervical dysplasia and cancer.
会议
Cancer Immunoprevention for Cervical Cancer Prevention
Human papillomavirus (HPV) is responsible for nearly all cervical cancer cases (99.7％) and an estimated 5％ of all cancers worldwide.Recently, HPV associated orophryngeal cancers are also on the rise.
会议
WOMEN'S HEALTH INITIATIVE IN CHINA-CERVICAL CANCER PREVENTION PROGRAM Cervical Cancer Preventio
Objectives:There are 135,000 new cases of cervical cancer in China every year and the screening rate is less than 60％.
会议